Skip to content
Obsidio
  • Technology
  • Applications
  • About Us
  • Press
  • Publications
  • Contact

Author: bhadmin

Fast Company recognizes Obsidio among 2022 honorees in Health Category of World Changing Ideas

Obsidio recognized as winner of 2021 MedTech Innovation of the Year

PM360 Magazine selects Obsidio as one of the most innovative startups of the year

Mayo Clinic researchers develop a tissue-derived bioactive gel to stop bleeding, aid in vascular healing

Preclinical studies at Mayo Clinic demonstrate new ways to stop bleeding

Obsidio, Inc. Closes $3 Million Round, Receives Grant from The National Science Foundation and Welcomes New Board Member

Obsidio, Inc. is selected as one of the five 2020 BIO Startup Stadium Winner!

Obsidio, Inc. is selected as a 2020 Rosenman Innovator!

Obsidio announces the formation of clinical advisory board

  • 1
  • 2
  • Next Page
  • Technology
  • Applications
  • About Us
  • Press
  • Publications
Obsidio

© Copyright 2022 Obsidio Privacy Policy Web Design by Beam & Hinge

  • Twitter
  • Linked-in

Obsidio's portfolio of products is under development and does not have marketing clearance or approval in any market at this time. For investigational use only. Not available for sale.